FCA
IMGN

Florence Capital Advisors’s Immunogen Inc IMGN Stock Holding History

Florence Capital Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$16K Hold
2,500
– – 0.02% 52
2017
Q3 		$19K Hold
2,500
– – 0.02% 49
2017
Q2 		$12K Hold
2,500
– – 0.04% 58
2017
Q1 		$10K Hold
2,500
– – 0.03% 60
2016
Q4 		$5K Buy
+2,500
New +$5.02K 0.01% 67

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Florence Capital Advisors's IMGN Position: Q4 2017 in Review

Florence Capital Advisors held its Immunogen Inc (IMGN) position steady in Q4 2017 at 2,500 shares worth $16K. The position accounts for 0.02% of the portfolio, ranked #52.

Florence Capital Advisors first reported a position in IMGN in Q4 2016 and has held it in 5 quarters since. The position peaked at $19K in Q3 2017. 200 funds tracked by Wall St. Rank hold IMGN as of Q4 2017.

  • Florence Capital Advisors held 2,500 shares of Immunogen Inc worth $16K as of Q4 2017.
  • Florence Capital Advisors left its Immunogen Inc share count unchanged in Q4 2017.
  • Immunogen Inc made up 0.02% of Florence Capital Advisors's portfolio in Q4 2017, its #52 holding.
  • Florence Capital Advisors first reported a position in Immunogen Inc in Q4 2016 and has held it in 5 quarters since.
  • Florence Capital Advisors's Immunogen Inc position peaked at $19K in Q3 2017.
  • 200 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2017.

Based on Florence Capital Advisors's 13F filing for Q4 2017, filed 12 Feb 2018.